Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("YM 022")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

The effects of intrathecally administered FK480, a cholecytokinin-A receptor antagonist, and YM022, a cholecystokinin-B receptor antagonist, on the formalin test in the ratYAMAMOTO, T; NOZAKI-TAGUCHI, N.Anesthesia and analgesia. 1996, Vol 83, Num 1, pp 107-113, issn 0003-2999Article

Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula ratsDING, X.-Q; KITANO, M; HAKANSON, R et al.Pharmacology & toxicology. 1998, Vol 82, Num 4, pp 177-182, issn 0901-9928Article

Characterization of YM022 : its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilizationSAITA, Y; YAZAWA, H; HONMA, Y et al.European journal of pharmacology. Molecular pharmacology section. 1994, Vol 269, Num 2, pp 249-254, issn 0922-4106Article

CCK receptor antagonistsDUNLOP, J.General pharmacology. 1998, Vol 31, Num 4, pp 519-524, issn 0306-3623Article

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea] : An irreversible cholecystokinin type-B receptor antagonistDUNLOP, J; BRAMMER, N; EVANS, N et al.Biochemical pharmacology. 1997, Vol 54, Num 1, pp 81-85, issn 0006-2952Article

Reversibility of cholecystokinin-N/gastrin receptor blockade : A study of the gastrin-ECL cell axis in the ratNORLEN, P; LINDSTRÖM, E; DING, X.-Q et al.Pharmacology & toxicology. 1999, Vol 84, Num 4, pp 159-164, issn 0901-9928Article

Constitution of colloidal particles formed from a solid dispersion systemYANO, K; KAJIYAMA, A; HAMADA, M et al.Chemical and pharmaceutical bulletin. 1997, Vol 45, Num 8, pp 1339-1344, issn 0009-2363Article

YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glandsATTOUB, S; MOIZO, L; LAIGNEAU, J. P et al.Fundamental & clinical pharmacology. 1998, Vol 12, Num 3, pp 256-262, issn 0767-3981Conference Paper

Long-lasting cholecystokinin2 receptor blockade after a single subcutaneous injection of YF476 or YM022KITANO, M; NORLEN, P; DING, X.-Q et al.British journal of pharmacology. 2000, Vol 130, Num 3, pp 699-705, issn 0007-1188Article

In vitro stability and in vivo absorption studies of colloidal particles formed from a solid dispersion systemYANO, K; KAJIYAMA, A; YAMAZAKI, S et al.Chemical and pharmaceutical bulletin. 1996, Vol 44, Num 12, pp 2309-2313, issn 0009-2363Article

New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonistsSATOH, M; KONDOH, Y; OKAMOTO, Y et al.Chemical and pharmaceutical bulletin. 1995, Vol 43, Num 12, pp 2159-2167, issn 0009-2363Article

  • Page / 1